Guest Spotlight: Dr. Linda Glaser How Do You Define Patient Engagement?

Guest Spotlight: Dr. Linda Glaser How Do You Define Patient Engagement?

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 3 min read

We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.

Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.

While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.

What is most rewarding to you as you consider your contribution to clinical trial research?

The ability to help advance science and treat disease.

How do you define patient engagement? What does that term mean to you?

To me, patient engagement is primarily about communication. We strive to make sure that the patient feels comfortable about participating in the study and enable a back and forth dialogue.

Can you share any examples within a study structure that showed a notable difference in patient engagement?  

At our research clinic, we strive to have the patient feel that we have their best interests at heart and that we will protect them from any potential harm. We foster an inclusive environment and ensure that proper time is spent with each patient so they feel valued as participants and collaborators in the study rather than feeling like guinea pigs. When patients feel supported and informed, we find their study participation and experience is improved.

What are your most compelling reasons for accepting a clinical trial into your research facility?

I take on studies that I think I can recruit for and will be successful at.

What do Sponsors / CROs do well?

I generally think that Sponsors/CROs are responsive to questions -- even with so many people to communicate with!

What would be on your wish list for Sponsors / CROs to consider to foster stronger partnerships with medical sites?

First and foremost, I appreciate studies that focus on protocol quality and design with site feasibility in mind, specifically focusing on entry criteria and schedule of visits and procedures.

After that, my focus is on having open and efficient communication, training and interactions supporting the site through the lifecycle of the study, from the patient recruitment phase to study close-out and inspection preparation. Getting enough recruitment support before there is concern, with proactive assistance with recruitment strategies to ensure success, is greatly preferred.

Lastly, CRA turnover is a very large problem.  It can be disruptive to the sites and results in repetition of work already done.

You mentioned training support. Are there training tactics you have found more successful than others?

My goal is to ensure that my staff is adequately trained and knowledgeable regarding the protocol and indication under study. Online tutorials seem to really engage them and they can take them at their own time versus online webinars at set times.   

Topics: Patient Retention, Patient Recruitment, Physician Engagement, Conferences, Site Engagement, Clinical Research, Patient Experience, Pharma15 Live!